In over three decades in medicine, Lishan Aklog has experienced breakthrough moments as a heart surgeon in the US, UK and France, and since 2018, as chair and CEO of Lucid Diagnostics, which is a subsidiary of PAVMed.
But potentially the biggest moment is yet to arrive: Lucid Diagnostics will hold a pre-submission meeting with Medicare’s MolDX program...